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The transcription factor E2A controls the initiation of
B lymphopoiesis, which is arrested at the pre-pro-B
cell stage in E2A-deficient mice. Here, we demon-
strate by conditional mutagenesis that E2A is essen-
tial for the development of pro-B, pre-B, and imma-
ture B cells in the bone marrow. E2A is, however,
dispensable for the generation of mature B cells and
plasma cells in peripheral lymphoid organs. In con-
trast, germinal center B cell development is impaired
in the absence of E2A despite normal AID expression
and class-switch recombination. Molecular analysis
revealed that E2A is required not only for initiating
but also for maintaining the expression of Ebf1,
Pax5, and the B cell gene program in pro-B cells. No-
tably, precocious Pax5 transcription from the Ikzf1
locus promotes pro-B cell development in E2A-
deficient mice, demonstrating that ectopic Pax5
expression is sufficient to activate the B lymphoid
transcription program in vivo in the absence of E2A.
INTRODUCTION
A dynamic network of transcriptional regulators controls the en-
try of lymphoid progenitors into the B cell pathway and the sub-
sequent developmental progression to terminally differentiated
plasma cells (Nutt and Kee, 2007). Early specification of the
B-lymphoid lineage requires the transcription factor E2A, which
is encoded by the Tcfe2a gene (Murre, 2005). Tcfe2a transcripts
give rise, by alternative splicing, to the E2A isoforms E12 and E47
differing only in the basic helix-loop-helix (bHLH) domain, which
mediates protein dimerization and DNA binding to the E-box
motif CANNTG. E2A and the related E2-2 and HEB proteins con-
stitute the E protein family and normally form heterodimers with
tissue-restricted bHLH regulators except in the B lymphoid
lineage, in which the abundantly expressed E2A proteins pre-
dominantly exist as homodimers. The activity of E proteins can
be controlled by association with one of four Id (inhibitor of differ-
entiation) proteins, which sequester E proteins into DNA-binding
incompetent heterodimers (reviewed by Murre [2005]).Hematopoietic stem cells (HSCs) develop into B cells by first
generating lymphoid-primed multipotent progenitors, which
subsequently differentiate to common lymphoid progenitors
(CLPs) with their characteristic B, T, and natural killer cell poten-
tial (Nutt and Kee, 2007). Entry of CLPs into the B cell lineage crit-
ically depends on the transcription factors E2A, EBF1, and Pax5
(Nutt and Kee, 2007). In the absence of E2A, the differentiation of
CLPs along the B cell pathway is stringently blocked at the pre-
pro-B cell stage (Bain et al., 1994; Zhuang et al., 1994; Borghesi
et al., 2005). In contrast, HEB or E2-2 deficiency only mildly
affects B cell development by causing a partial block at the
pro-B cell stage (Zhuang et al., 1996; Wikstrom et al., 2006).
E2A-deficient CLPs and pre-pro-B cells fail to undergo DH-JH
rearrangements at the immunoglobulin heavy-chain (IgH) locus
because of the absence of Rag1 expression and thus V(D)J
recombinase activity (Bain et al., 1994; Borghesi et al., 2005).
Whereas these E2A-deficient progenitors express Il7r (IL-7Ra),
Cd79b (Igb), and Igmo transcripts, they transcribe Ebf1 only at
a low amount and fail to express Pax5, Cd19, Cd79a (Igb,
mb1), and Igll1 (l5), suggesting that E2A acts upstream of
EBF1 and Pax5 in the initiation of the B cell gene-expression pro-
gram (Bain et al., 1994; Bain et al., 1997). Consistent with this hy-
pothesis, the Ebf1 gene is rapidly activated in long-term in vitro-
cultured E2A-deficient progenitors upon expression of inducible
E2A activity (Ikawa et al., 2004). Moreover, E2A binds to and ac-
tivates the distal promoter of the Ebf1 gene (Smith et al., 2002;
Roessler et al., 2007). Notably, forced retroviral expression of
EBF1, but not of Pax5, restores pro-B cell development of in vitro-
cultured E2A-deficient progenitors, further indicating that Ebf1 is
a critical E2A target gene at the onset of B lymphopoiesis (Seet
et al., 2004).
Within the B lymphoid lineage, E2A cooperates with EBF1 to
control B cell development by coordinately regulating B cell-spe-
cific genes (O’Riordan and Grosschedl, 1999; Sigvardsson et al.,
1997). E2A is also a key regulator of Igk rearrangements, consis-
tent with the fact that E2A was initially identified as a DNA-bind-
ing activity interacting with the kE2 site in the intronic enhancer
(iEk) of the Igk locus (Murre et al., 1989). Deletion of the kE1
and kE2 E-boxes impairs Igk rearrangements to the same extent
as deletion of the entire iEk enhancer (Inlay et al., 2004). More-
over, ectopic expression of E2A in combination with RAG1
and RAG2 is sufficient for inducing endogenous Igk germline
transcription and Vk-Jk recombination in nonlymphoid cellsImmunity 28, 751–762, June 2008 ª2008 Elsevier Inc. 751
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pre-B cells are furthermore unable to undergo Vk-Jk rearrange-
ments in the absence of E2A (Lazorchak et al., 2006a). Consis-
tent with a stringent E2A requirement for Igk recombination, sec-
ondary rearrangements and thus receptor editing are impaired in
immature B cells of heterozygous Tcfe2a+/ mice (Quong et al.,
2004).
Although E2A is essential for the initiation of Ebf1 transcription
and the B cell gene-expression program at the start of B cell de-
velopment, it is less clear whether it is also required for maintain-
ing B cell-specific gene expression after B lineage commitment.
In vitro cultured E2A-deficient pro-B cells, which are rescued by
ectopic EBF1 expression, undergo normal V(D)J recombination
at the IgH locus and show normal expression of B-lymphoid
genes (Seet et al., 2004). Likewise, Tcfe2a inactivation in Ab-
MuLV-immortalized pro-B cells fails to interfere with the expres-
sion of EBF1, Pax5 and their target genes (Greenbaum et al.,
2004; Lazorchak et al., 2006b). On the other hand, committed
pro-B cells undergo rapid growth arrest and apoptosis upon in-
activation of all E proteins by retroviral expression of the HLH an-
tagonist Id3 (Kee et al., 2001). Taken together, these in vitro data
suggest that E2A is dispensable for pro-B cell development
because the remaining, lowly expressed HEB and E2-2 proteins
are sufficient to cooperate with EBF1 and Pax5 in maintaining
B cell-specific gene expression. Forced expression of Id2 or
Id3 was also used to study the role of E proteins in activated
splenic B cells, indicating that E2A (probably together with
E2-2 and HEB) controls immunoglobulin class-switch recombi-
nation (Quong et al., 1999) by binding to and regulating the Aicda
(AID) gene (Sayegh et al., 2003; Gonda et al., 2003). The interpre-
tation of these experiments is, however, not straightforward
because Id proteins are thought to interact not only with bHLH
proteins but also other transcription factors including the
Retinoblastoma and related pocket proteins and ETS-domain
transcription factors as well as Pax5 (Norton, 2000; Roberts
et al., 2001).
Here, we have studied the in vivo function of E2A throughout B
lymphopoiesis by conditional mutagenesis with stage-specific
Cre lines. These experiments have provided insight into the es-
sential role of E2A in the development of bone marrow pro-B,
pre-B, and immature B cell and the formation of germinal center
(GC) B cells in peripheral lymphoid organs.
RESULTS
Strategy of Conditional Tcfe2a Mutagenesis
We generated a floxed (fl) Tcfe2a allele with the following fea-
tures (Figures S1A available online). The insertion of loxP sites
upstream of exon 17 and downstream of exon 19 facilitated
Cre-mediated excision of the two alternatively spliced exons
18 coding for the E12 and E47 DNA-binding domains, thus re-
sulting in a Tcfe2a null allele (Zhuang et al., 1994). A Gfp gene,
which was fused in frame to the N-terminal codons and 30 splice
site of exon 17, was inserted at the 30 end of the Tcfe2a gene in
such a manner that Cre-mediated inactivation leads to the ex-
pression of an E2A-GFP fusion protein. Six copies of the SV40
polyadenylation region were introduced downstream of the last
Tcfe2a exon to prevent RNA splicing to the Gfp exon prior to
Cre-mediated deletion. Finally, the presence of frt sites on either752 Immunity 28, 751–762, June 2008 ª2008 Elsevier Inc.side of the Gfp-neo expression cassette facilitated the genera-
tion of a deleted (D) allele lacking the Tcfe2a exons 17–19 and
Gfp gene by sequential Cre and Flp recombination. We crossed
heterozygous Tcfe2afl/+mice with transgenicCre and Flp lines to
obtain Tcfe2agfp/+ and Tcfe2aD/+ mice (Figure S1B). Hematopoi-
etic-specific deletion of the floxed Tcfe2a allele by the Vav-cre
transgene (de Boer et al., 2003) resulted in Tcfe2agfp/gfp progen-
itors and thymocytes that exclusively expressed the E2A-GFP
fusion protein instead of full-length E2A (Figure S1C). Conse-
quently, no committed c-Kit+CD19+ pro-B cells were generated
in the bone marrow of Vav-cre Tcfe2afl/fl mice (Figure S1D), thus
recapitulating the early developmental block of Tcfe2a/ mice
(Bain et al., 1994; Zhuang et al., 1994).
To investigate the B lymphoid function of E2A, we used differ-
entCre lines to delete the floxed Tcfe2a allele at distinct stages of
B cell development. The Gfp indicator gene allowed us to trace
and quantify B lymphocytes with conditional Tcfe2a deletion at
different stages by comparing the GFP expression profiles of
experimental Cre+ Tcfe2afl/D and control Cre+ Tcfe2afl/+ mice.
This experimental strategy is based on the assumption that the
heterozygous Tcfe2agfp/+ mouse has no, or only a weak, B cell
developmental defect. Indeed, the numbers of different B cell
types in the bone marrow and spleen were similar or only slightly
reduced in Tcfe2agfp/+ mice compared to wild-type mice
(Figure S2), indicating that heterozygous Tcfe2a mutant mice
on a C57BL/6 background exhibit only a mild haploinsufficient
phenotype in adult B lymphopoiesis in contrast to fetal B cell
development (Zhuang et al., 1994; O’Riordan and Grosschedl,
1999). We next analyzed GFP expression in early progenitors
anddifferent hematopoietic lineages of Tcfe2agfp/+mice (Figure 1
and Figure S3). Upon differentiation of HSCs to plasma cells,
GFP expression is upregulated at the transition from multipotent
progenitors (LSK cells) to CLPs and pre-pro-B cells, remains
high in pro-B, pre-B and immature B cells, starts to be downreg-
ulated in immature B cells of the spleen to reach relatively low
levels in follicular (FO) B cells and plasma cells, whereas interme-
diate GFP levels are observed in marginal zone (MZ) B cells, ger-
minal center (GC) B cells, and peritoneal B1a cells. These results
revealed a dynamic E2A expression pattern, which substantially
extends previous expression data (Quong et al., 2004; Zhuang
et al., 2004).
Essential Role of E2A in Pre-B and Immature
B Cell Development
To study the role of E2A in pre-B and immature B cells, we took
advantage of the fact that the Cd19-cre line leads to inefficient
and thus progressive gene deletion at subsequent stages of B
cell development (Rickert et al., 1997). Total B cell numbers in
the bone marrow of Cd19-cre Tcfe2afl/D mice were reduced to
30% of those of control Tcfe2afl/flmice (Figure 2A). Pro-B and re-
circulating B cells in Cd19-cre Tcfe2afl/D mice were decreased
by half, whereas pre-B cell and immature B cell numbers were
reduced to 18% of those of control mice (Figure 2A). As pre-
dicted by inefficient deletion of Tcfe2a, GFP expression was
detected only in a subpopulation of pre-B cells in control Cd19-
cre Tcfe2afl/+ mice (Figure 2C). These GFP+ pre-B cells were,
however, absent in Cd19-cre Tcfe2afl/D mice, regardless of the
presence or absence of the Vav-Bcl2 transgene (Figure 2C).
GFP+ pre-B cells could also not be detected in Cd19-cre
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used instead of CD25 to identify pre-B cells (CD2+CD19+IgM
cells; data not shown). Similar to the situation with pre-B cells,
GFP+ immature B cells were absent in the bone marrow of
Cd19-cre Tcfe2afl/D mice irrespective of Bcl2 expression
(Figure 2D). We conclude therefore that pre-B cells and imma-
ture B cells require E2A for their development because they
are lost upon conditional Tcfe2a inactivation.
E2A Is Dispensable for the Generation and Viability
of Mature B Cells
The spleen of Cd19-cre Tcfe2afl/D mice contained half the num-
ber of B cells compared to control Tcfe2afl/fl mice (Figure 2B).
Moreover, immature, transitional, and mature B cells were
equally reduced to 50%,which is probably caused by decreased
B cell production in the bonemarrow ofCd19-cre Tcfe2afl/Dmice
rather than by a functional dependency of splenic B cells on E2A
(Figure 2B). To further investigate the role on E2A in late B-lym-
phopoeisis, we generated a Cd23-cre transgene by inserting
a Cre gene (linked via IRES to a human Cd5 indicator gene)
into exon 2 of the mouse Cd23 locus (Figure S4A). This insertion
into a Cd23 bacterial artificial chromosome (BAC) brought the
Cre gene under the control of the B cell-specific Cd23 promoter
(Kondo et al., 1994) (Figure S4A). Consistent with the absence of
CD23 expression in early B cell development, GFP expression
and thus Cre activity was not detected in pro-B, pre-B, and
Figure 2. Strict Dependency of Pre-B
and Immature B Cell Development on E2A
Function
(A and B) Absolute cell numbers were determined
for different B cell developmental stages in the
bone marrow (A) and spleen (B) of Tcfe2afl/fl mice
(gray bars; n = 6 [A]; n = 3 [B]) and Cd19-cre
Tcfe2afl/D mice (black bars; n = 8 [A]; n = 4 [B]) at
the age of 6 weeks. The average cell numbers
with their standard deviations are shown for the in-
dicated number (n) of mice analyzed.
(C and D) Loss of pre-B and immature B cells upon
Cd19-cre-mediated Tcfe2a inactivation. Bone
marrow of the indicated genotypes was analyzed
by flow cytometry, and GFP expression is dis-
played for the CD19+CD25+IgM pre-B cells (C)
and immature CD19+IgM+IgD B cells (D).
Figure 1. E2A Expression during the
Differentiation of Hematopoietic Stem Cells
to Plasma Cells
Tcfe2agfp/+ (black line) and wild-type (dashed line)
mice were analyzed by flow cytometry for GFP ex-
pression in different progenitor and B cell stages.
The different cell types were defined as described
in Supplemental Experimental Procedures. The
following abbreviations are used: MPP, multipo-
tent progenitors (LSK); CLP, common lymphoid
progenitors; imm, immature; trans, transitional;
MZ, marginal zone; FO, follicular; GC, germinal
center; PC, plasma cells; and PerC, peritoneal
cavity. The E2A expression pattern in other hema-
topoietic lineages is shown in Figure S3.Immunity 28, 751–762, June 2008 ª2008 Elsevier Inc. 753
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(Figure S4B). In these heterozygous mice, the Gfp gene was ac-
tivated in a subpopulation of immature splenic B cells and was
then homogenously expressed in transitional, MZ, and follicular
(FO) B cells, indicating that the Cd23-cre transgene leads to
complete Tcfe2a inactivation in mature B cell types of the spleen
(Figure S4C; see Figure S5 for further characterization of the
Cd23-cre line 5).
The splenic B cell subsets wereminimally reduced inCd23-cre
Tcfe2afl/Dmice compared toCd23-cre Tcfe2afl/+mice except for
MZ B cells, which were slightly increased in the absence of E2A
(Figure 3A). By PCR genotyping, we detected only the Tcfe2agfp
allele in sorted splenic IgDhiIgMlo B cells fromCd23-cre Tcfe2afl/D
mice, thus indicating full conversion of the Tcfe2afl to the
Tcfe2agfp allele in these mature B cells (Figure 3B). Immunoblot
analysis also failed to detect the wild-type E2A protein in mature
B cells of Cd23-cre Tcfe2afl/D mice (Figure 3C). The absence of
E2A furthermore led to the loss of E2A binding at known E2A tar-
get sequences in mature B cells of Cd23-cre Tcfe2afl/D mice, as
shown by chromatin-immunoprecipitation analysis (Figure S6).
Complete Tcfe2a inactivation was also confirmed by homoge-
nous GFP expression in transitional, MZ, and mature FO B cells
of Cd23-cre Tcfe2afl/D mice (Figure 3D). Interestingly, the IgM
and IgD receptors were expressed at identical levels on mature
wild-type and E2A-deficient B cells (Figure S7) despite the fact
that E2A has been implicated in the transcriptional regulation
of several components of the BCR (Igk, Iga [CD79a], and Igb
[CD79b]) (Murre, 2005; Lazorchak et al., 2006b).
We next investigated the possibility that the loss of E2A may
be compensated by increased expression of Tcf4 and Tcf12
coding for the related E2-2 and HEB proteins, respectively.
The relative expression of the Tcfe2a, Tcf4, and Tcf12 transcripts
was compared by RNase protection assay in wild-type pro-B
and mature B cells as well as in mature E2A-deficient B cells
(Cd23-cre Tcfe2afl/D). As shown in Figure 3E and Figure S8,
this analysis revealed that Tcf4 was similarly expressed in all
B lymphocytes, whereas the transcripts of Tcfe2a and Tcf12
were reduced 3- and 2-fold, respectively, during the develop-
ment of wild-type pro-B to mature B cells. Importantly, Tcf4 or
Tcf12 were similarly expressed in wild-type and E2A-deficient
mature B cells, indicating that the loss of E2A was not compen-
sated by increased expression of Tcf4 or Tcf12. In the absence of
compensation by other E proteins, we conclude that E2A plays
a minor role in the generation and survival of splenic B cells.
Function of E2A in Germinal Center B Cell Development
To study the role of E2A in GC B cell formation, we generated an
Aicda-cre transgene by inserting the Cre-coding sequence
(linked via IRES to a human Cd2 gene) into exon 2 of the Aicda
(AID) gene (Figure S9A), which is selectively expressed in GC B
cells (Muramatsu et al., 1999). The expression pattern of the en-
dogenous Aicda gene was recapitulated in Aicda-cre Tcfe2afl/+
mice because hCD2 (Aicda) and GFP (Cre) expression could
be detected only in GC B cells (Fas+PNA+B220+) of the spleen
and Peyer’s patches 8 days after immunization with sheep red
blood cells (Figure S9; see Figure S10 for further characterization
of the Aicda-cre line 9). At day 4 of immunization, the GC B cells
were already reduced in the spleen of Aicda-cre Tcfe2afl/D mice
and then remained at 7- and 4-fold-lower numbers at day 8 and754 Immunity 28, 751–762, June 2008 ª2008 Elsevier Inc.12 in comparison to control Tcfe2afl/fl and Tcfe2afl/D mice
(Figure 4A). Importantly, the majority (93%) of the GC B cells in
Aicda-cre Tcfe2afl/D mice uniformly expressed GFP and were
Figure 3. Minor Role of E2A in Controlling the Generation and
Viability of Splenic B Cells
(A) Splenic B cell numbers. The relative percentage of the different B cell types
was determined by flow-cytometric analysis of splenocytes (within the lym-
phocyte gate) from Cd23-cre Tcfe2afl/+ mice (gray bars; n = 4) and Cd23-cre
Tcfe2afl/Dmice (black bars; n = 4) at the age of 6 weeks. The average percent-
age of cells with its standard deviation is shown for the indicated number (n) of
mice analyzed.
(B) PCR genotyping of Tcfe2a alleles in sorted splenic IgDhiIgMlo B cells of the
indicated genotypes. The Tcfe2aD allele is not detected with the primer com-
bination used.
(C) Absence of E2A protein in sorted splenic IgDhiIgMlo B cells from Cd23-cre
Tcfe2afl/D mice, as shown by immunoblot analysis with an E2A antibody.
(D) GFP expression in splenic B cells of Tcfe2afl/+ (dashed line), Cd23-cre
Tcfe2afl/+ (blue), and Cd23-cre Tcfe2afl/D (red) mice. The B cell types were de-
fined by the gates shown for the Cd23-cre Tcfe2afl/D genotype.
(E) Relative expression of Tcfe2a, Tcf4, and Tcf12mRNA in pro-B and mature
B cells. Total RNA of wild-type pro-B cells and mature B cells from the lymph
nodes of wild-type (+/+) andCd23-cre Tcfe2afl/D (gfp/D) mice was analyzed by
RNase protection assay (shown in Figure S8), and the Tcfe2a, Tcf4, and Tcf12
mRNA signals were quantified and normalized to the reference S16 RNA.
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pression could not prevent the loss of GC B cells in Vav-Bcl2
Aicda-cre Tcfe2afl/D mice at day 4 during early GC B cell devel-
opment (Figure 4A). Bcl2 could, however, progressively rescue
GC B cell numbers at day 8 and 14 most probably by interfering
with the normal apoptotic elimination of centrocytes expressing
low-affinity BCRs (Figure 4A). These data therefore indicate
a nonpermissive role of E2A in GC B cell formation.
Because activation of the Aicda gene occurs only upon initia-
tion of GC development (Muramatsu et al., 1999), the Aicda-cre
transgene cannot be used to study the function of E2A at the
start of GC B cell formation. For this purpose, we used the
Cd23-cre transgene because all FO B cells giving rise to GC
B lymphocytes already lack E2A function in Cd23-cre Tcfe2afl/D
mice prior to immunization (Figures 3B–3D). At day 4 and 8 after
immunization with sheep red blood cells, GC B cells were still
generated in the spleen of Cd23-cre Tcfe2afl/D mice, although
Figure 4. Inefficient GC B Cell Development
in the Absence of E2A
(A) Reduced GC B cell formation in Aicda-cre
Tcfe2afl/D mice. The abundance of GC B cells
(PNA+Fas+B220+) in mice of the indicated geno-
types was determined as percentage relative to
total lymphocytes (within the lymphocyte gate) af-
ter 4, 8, and 14 days of immunization with sheep
red blood cells. The average percentage of GC B
cells with its standard deviation is shown for the in-
dicated number (n) of mice analyzed.
(B) Inefficient GC B cell development in Cd23-cre
Tcfe2afl/D mice. The percentage of GC B cells of
the indicated genotypes was determined relative
to total B220+ B cells after 4 and 8 days of immu-
nization with sheep red blood cells.
(C and D) Immunophenotype of E2A-deficient GC
B cells. Representative FACS analyses of GC B
cells are shown for Aicda-cre Tcfe2afl/D (C),
Cd23-cre Tcfe2afl/D (D) and control Tcfe2afl/fl
mice (C and D) 8 days after immunization with
sheep red blood cells. The size distribution, BrdU
incorporation, and expression of GFP, CD23,
CD38, and IgG1 are indicated for GC B cells of
control (dashed line) and experimental (black
line) mice.
(E) Reduced number and smaller size of germinal
centers in the spleen of Cd23-cre Tcfe2afl/D and
Aicda-cre Tcfe2afl/Dmice at day 8 after immuniza-
tion with sheep red blood cells. Cryosections of
the spleen were stained with a FITC-anti-IgD
antibody (blue) and biotinylated lectin peanut
agglutinin (PNA, brown), and this was followed
by detection with an alkaline phosphatase-cou-
pled anti-FITC antibody and horseradish peroxi-
dase-conjugated streptavidin.
at 3- to 5-fold-lower numbers relative to
control Tcfe2afl/fl and Tcfe2afl/D mice
(Figure 4B). Histological analysis of the
spleen 8 days after immunization re-
vealed fewer and smaller germinal cen-
ters containing PNA+ GC B cells (brown)
both in Cd23-cre Tcfe2afl/D and Aicda-
cre Tcfe2afl/D mice compared to the
abundant presence of large GCs in control Tcfe2afl/+ mice
(Figure 4E). We conclude therefore that GC B cell development
is still initiated but subsequently maintained at a low degree in
the absence of E2A.
Flow-cytometric analysis of splenocytes at day 8 of immuniza-
tion revealed that IgG1 was expressed on one-third of all E2A-
deficient GC B cells in both Cd23-cre Tcfe2afl/D mice and
Aicda-cre Tcfe2afl/D mice, similar to control Tcfe2afl/fl mice
(Figure 4D; data not shown). Moreover, the E2A-deficient splenic
B cells ofCd23-cre Tcfe2afl/Dmice also underwent normal class-
switch recombination to IgG3 and IgG1 upon in vitro stimulation
with lipopolysaccharide (LPS) alone or LPS plus IL-4, respectively
(Figure S11). Hence, class-switch recombination to IgG1 and IgG3
occurs normally in the absence of E2A. E2A-deficient and control
GC B cells also exhibited the same size distribution and BrdU
incorporation, indicating that the loss of E2A does not affect
the proliferation of GC B cells in vivo (Figures 4C and 4D; dataImmunity 28, 751–762, June 2008 ª2008 Elsevier Inc. 755
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(A) Plasma cell development. Plasma cells in the bone marrow (BM) of Aicda-cre Tcfe2afl/D (black line) and control Tcfe2afl/fl (dashed line) were identified as
LinCD28+CD138+ cells (Delogu et al., 2006) and analyzed for GFP expression 14 days after immunization with sheep red blood cells.
(B) Frequency of antibody-secreting cells (ASCs). At day 14 of immunization with sheep red blood cells, ASCs producing different immunoglobulin isotypes were
determined by ELISPOT assay in the spleen of Tcfe2afl/D (n = 5) and Aicda-cre Tcfe2afl/D (n = 6) mice. The average number of ASCs with its standard deviation is
shown for the indicated number (n) of mice analyzed.
(C) NP-specific immune responses. Cd23-cre Tcfe2afl/+ (fl/+) and Cd23-cre Tcfe2afl/D (fl/D) mice were immunized with NP-KLH (in Alum) and boosted with NP-
KLH (in PBS) 6 weeks later. After 2, 4, and 8 weeks, the serum titers of NP-specific antibodies were determined by ELISA with NP3-BSA- or NP30-BSA-coated
plates for detecting high-affinity or total antibodies, respectively. NP-specific IgG1 concentrations (mg/ml) were determined relative to a standard NP-binding
IgG1 antibody, whereas IgG2a and IgG3 amounts are indicated as relative units (RU) measured relative to the same standard NP-binding IgG1 antibody.not shown). Likewise, E2A-deficient splenic B cells proliferated
normally in response to in vitro stimulation with LPS or LPS
plus IL-4, as shown by CFSE dilution experiments (Figure S11A).
Consistent with the absence of a class-switch recombination
phenotype, semiquantitative RT-PCR analysis revealed similar
expression of Aicda mRNA, Ig1-Cg1 germline transcripts and
Im-Cg1 postswitch transcripts in sorted GC B cells irrespective
of the presence or absence of E2A (Figure S12). Most other B
cell-specific genes analyzed were also similarly transcribed in
control and E2A-deficient GC B cells except for Pax5 and its tar-
get genes Irf8, Ikzf3 (Aiolos), Klf2, and Blnk (Schebesta et al.,
2007), whose expression was moderately elevated in Aicda-cre
Tcfe2afl/D GC B cells relative to Cd23-cre Tcfe2afl/D and control
Tcfe2afl/fl GC B cells (Figure S12). In contrast, the expression
of CD23 and CD38 remained high in all E2A-deficient GC B cells
of both the Aicda-cre Tcfe2afl/D and Cd23-cre Tcfe2afl/D geno-
types in contrast to their downregulation in control GC B cells
(Figures 4C and 4D and Figure S12B). Together, our data dem-
onstrate that E2A is not involved in GC B cell survival, prolifera-
tion, or class-switch recombination but instead controls another
so-far-unknown aspect of GC B cell development.756 Immunity 28, 751–762, June 2008 ª2008 Elsevier Inc.Plasma Cell Development in the Absence of E2A
To study the role of E2A in terminal differentiation, we analyzed
plasma cells by FACS and ELISPOT assays 14 days after immu-
nization of control and Aicda-cre Tcfe2afl/D mice with sheep red
blood cells. The bone marrow of Aicda-cre Tcfe2afl/D mice
contained long-lived CD28+CD138+Lin (CD4CD8aF4/80
CD21) plasma cells (Delogu et al., 2006), which were all GFP+
and thus E2A deficient (Figure 5A). Moreover, similar numbers
of IgA-, IgG1-, and IgG2b-secreting cells were detected in
addition to IgM-producing cells in the spleen of Aicda-
cre Tcfe2afl/D and control Tcfe2afl/D mice, confirming that the
absence of E2A does not affect class-switch recombination to
these immunoglobulin isotypes in vivo (Figure 5B). E2A defi-
ciency resulted, however, in a moderate reduction of IgG2a-
and IgG3-secreting cells (Figure 5B). Next, Cd23-cre Tcfe2afl/+
and Cd23-cre Tcfe2afl/D mice were intraperitoneally injected
with the T cell-dependent antigen NP-KLH at day 0 and after 6
weeks, whereas serum immunoglobulin titers were determined
by ELISA at 2, 4, and 8 weeks. Despite the observed reduction
of E2A-deficient GC B cells (Figure 4B), similar titers of NP-spe-
cific IgG1, IgG2a, or IgG3 were measured at the different time
Immunity
E2A-Dependent Control of B Lymphopoiesispoints in the presence or absence of E2A (Figure 5C), demon-
strating that the loss of E2A does not interfere with the generation
of all three isotypes in the primary and secondary (memory) im-
mune response (Figure 5C). Importantly, high-affinity antibodies
were produced at similar concentrations in E2A-deficient and
control plasma cells, suggesting that E2Amay also not be essen-
tial for somatic hypermutation of Ig genes (Figure 5C). Together,
these data show that functional memory B cells and plasma cells
develop quite normally in the absence of E2A.
E2A Maintains the B Cell Gene-Expression Program
in Committed Pro-B Cells
We next turned our attention to the function of E2A in committed
pro-B cells, which cannot be analyzed in Tcfe2a/ mice be-
cause of the developmental arrest at the pre-pro-B cell stage
(Borghesi et al., 2005). The Cd79a-cre line (also known to as
mb1-cre line; Hobeika et al., 2006) proved to be ideal for bypass-
ing this early developmental block because conditional Tcfe2a
inactivation led to GFP expression only in a small subset (6%–
8%) of CLPs and pre-pro-B cells in the bone marrow of hetero-
zygous Cd79a-cre Tcfe2afl/+ mice (Figure 6A). However, all
CD19+c-Kit+ pro-B cells of these control mice uniformly ex-
pressed GFP, demonstrating that the Cd79a-cre line efficiently
inactivates the floxed Tcfe2a allele only in committed pro-B cells
(Figure 6A). NoCD19+ pro-B cells could, however, be detected in
Cd79a-cre Tcfe2afl/Dmice (Figure 6B), indicating that committed
pro-B cells are lost in the absence of E2A. To confirm this result,
we used the CreED-30 transgene coding for a Cre-estrogen re-
ceptor (ER) fusion protein, which facilitates gene deletion in cul-
tured pro-B cells after Cre-ER activation by 4-hydroxytamoxifen
(OHT) treatment (Schwenk et al., 1998). Whereas untreated pro-
B cells established from the bonemarrow ofCreED-30 Tcfe2afl/D
mice failed to express GFP, a majority of these cells rapidly
activated GFP expression within 1 day of OHT treatment
(Figure 6C). At day 2, the pro-B cell culture consisted of distinct
GFP+ and GFP cell populations. Whereas the GFP pro-B cells
were viable at day 3, the GFP+ pro-B cells were rapidly lost from
the culture (Figure 6C). Interestingly, Bcl2 expression could not
prevent the loss of GFP+ cells from OHT-treated pro-B cell cul-
tures isolated from Vav-Bcl2 CreED-30 Tcfe2afl/D mice (data
not shown). We conclude therefore that conditional Tcfe2a inac-
tivation leads to the loss of committed pro-B cells even in the
presence of the antiapoptotic Bcl2 protein.
We next sorted homogeneous populations of live GFP+ and
GFP pro-B cells (CD19+c-Kit+) from the bone marrow of
Cd19-cre Tcfe2afl/D mice (Figure 6D) to study the effect of E2A
on the expression of B cell-specific genes by semiquantitative
RT-PCR analysis (Figure 6E). Because Cd19 transcription en-
tirely depends on the B lineage commitment factor Pax5 (Nutt
et al., 1998), the Cd19-cre line induces Cre-mediated deletion
only in committed B lymphocytes of the hematopoietic system
(Xie et al., 2004). Consequently, the observed loss of Tcfe2a
mRNA in the GFP+ cells must have occurred in committed
CD19+ pro-B cells (Figure 6E). Both the E2A-deficient GFP+
and control GFP pro-B cells expressed similar amounts of the
ubiquitousPou2f1 (Oct1),Hprt, andGapdh transcripts, thus con-
firming that live GFP+ pro-B cells were analyzed (Figure 6E). Ex-
pression of the B lymphoid transcription factor genes Pax5 and
Ebf1 was, however, reduced by a factor of 25, whereas their tar-get genes Cd19, Blnk, Cd79a, and Igll1 (l5) as well as the Im
germline transcripts and rearranged VHJ558-DJCm mRNAs of
the IgH gene were expressed at 10-fold lower amounts in E2A-
deficient GFP+ pro-B cells compared to control GFP pro-B cells
(Figure 6E). Hence, E2A is required for maintaining the B cell-
specific expression program in committed pro-B cells in vivo.
Ectopic Pax5 Expression Induces Pro-B Cell
Development in the Absence of E2A
Retroviral Ebf1 expression in E47-deficient progenitors was pre-
viously shown to rescue pro-B cell development in vitro (Seet
et al., 2004). As anticipated, ectopic expression of a forced
Figure 6. E2A Dependency of the B Cell Gene-Expression Program
in Committed Pro-B Cells
(A) GFP expression in CLPs (LinIL-7Ra+Sca1loc-Kitlo), pre-pro-B cells
(LinCD19B220+c-Kitlo), and committed pro-B cells (CD19+c-Kit+) of
Cd79a-cre Tcfe2afl/+ mice.
(B) Absence of committed pro-B cells in the bone marrow of 2-week-old
Cd79a-cre Tcfe2afl/D mice.
(C) Loss of pro-B cells upon inducible Tcfe2a deletion. Pro-B cells fromCreED-
30 Tcfe2afl/Dmice were cultured in vitro for only 5 days prior to activation of the
Cre-ER fusion protein by the addition of 4-hydroxytamoxifen (OHT). GFP ex-
pression is shown only for live cells.
(D) FACS sorting and reanalysis of GFP+ and GFP pro-B cells from the bone
marrow of a 2-week-old Cd19-cre Tcfe2afl/D mouse.
(E) Downregulation of B cell-specific genes in committed pro-B cells upon
Tcfe2a inactivation. Expression of the indicated genes was analyzed by
RT-PCR with 5-fold serial dilutions of cDNA prepared from GFP+ and GFP
pro-B cells of a Cd19-cre Tcfe2afl/D mouse. ‘‘GLT’’ stands for germline
transcript.Immunity 28, 751–762, June 2008 ª2008 Elsevier Inc. 757
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the Ikzf1 (Ikaros) locus (Figure S13A) also promoted develop-
ment to c-Kit+B220+pro-B cells and later c-KitB220+ develop-
mental stages in the bone marrow of Vav-cre Tcfe2afl/fl Ikzf1E47
mice (Figure 7A). Unexpectedly, however, ectopic expression
of Pax5 from the Ikzf1Pax5 allele (Souabni et al., 2002) also res-
cued pro-B cell development in the fetal liver (Figure 7B) and
bone marrow (Figure 7C) of Vav-cre Tcfe2afl/fl Ikzf1Pax5/+ mice.
Importantly, all rescued pro-B cells uniformly expressed GFP
and were thus E2A deficient (Figures 7B and 7C). Moreover,
the Pax5-rescued E2A-deficient pro-B cells (Vav-cre Tcfe2afl/fl
Ikzf1Pax5/+) could be readily cultured in vitro as c-Kit+CD19+-
pro-B cells on OP9 feeder cells in the presence of IL-7
(Figure S13B).
PCR analysis of V(D)J recombination revealed a similar
frequency of DH-JH rearrangements in ex vivo-sorted control
pro-B cells and Pax5-rescued E2A-deficient pro-B cells
Figure 7. Ectopic Pax5 Expression Rescues
Pro-B Cell Development in the Absence of
E2A
(A) Rescue of pro-B cells (c-Kit+CD19+B220+) in
6-week-old Vav-cre Tcfe2afl/fl Ikzf1E47 mice.
(B and C) Rescue of pro-B cell development in
E18.5 fetal liver (B) and 2-week-old bone marrow
(C) of Vav-cre Tcfe2afl/fl Ikzf1Pax5 mice. Because
T cells of Ikzf1Pax5/+ mice express CD19 (Souabni
et al., 2002), we additional stained bone marrow
cells from Vav-cre Tcfe2afl/fl Ikzf1Pax5/+ mice (C)
for the lineage (Lin) markers CD8, TCRb, Ly6C,
and DX5 to eliminate contaminating T cells
(TCRb+CD8+), NK cells (DX5+), and plasmacytoid
dendritic cells (Ly6C+) from the pro-B cell gate.
We used an Ikzf1Pax5 allele lacking the IRES-Gfp
gene (Souabni et al., 2002) to allow detection of
GFP expression from the inactivated Tcfe2agfp
allele.
(D) Reduced VH-DJH rearrangements and absent
Vk-Jk recombination in sorted E2A-deficient pro-
B cells of Vav-cre Tcfe2afl/fl Ikzf1Pax5/+ mice.
(E) Maintenance of B cell gene expression in Pax5-
rescued E2A-deficient pro-B cells. Pro-B cells
were sorted as c-Kit+CD19+TCRbCD8DX5
Ly6C cells from the bone marrow of Vav-cre
Tcfe2afl/fl Ikzf1Pax5/+mice prior to RT-PCR analysis
of the indicated genes.
(Figure 7D), consistent with the RT-PCR
detection of similar Rag1 and Rag2 ex-
pression in both cell types (Figure 7E). In
contrast, proximal VH7183-DJH and distal
VHJ558-DJH rearrangements of the IgH
locus were significantly reduced (Fig-
ure 7D). As a consequence, rearranged
VH7183-DJH and VHJ558-DJH transcripts
were similarly decreased in Pax5-res-
cued E2A-deficient pro-B cells, whereas
the lower incidence of recombination-
mediated VH gene deletion increased
the amount of VH7183 and VHJ558 germ-
line transcripts (GLTs) compared to con-
trol Tcfe2afl/fl pro-B cells (Figure 7E). Interestingly, Vk-Jk recom-
bination of the Igk locus was entirely absent in Pax5-rescued
E2A-deficient pro-B cells (Figure 7D), in agreement with previous
evidence implicating E2A in the control of Igk rearrangements
(Murre, 2005).
RT-PCR analyses of ex vivo-sorted and in vitro-cultured pro-B
cells of the Tcfe2afl/fl and Vav-cre Tcfe2afl/fl Ikzf1Pax5/+ genotypes
revealed that Pax5 is 3-fold overexpressed from the Ikzf1Pax5
allele compared to the endogenous Pax5 gene of control pro-B
cells (Figure 7E and Figure S13C). The expression of all other B
cell-specific genes was similar or moderately elevated in
Pax5-rescued E2A-deficient pro-B cells relative to the control
cells (Figure 7E and Figure S13C). Together, these data demon-
strate that ectopic Pax5 expression from the Ikzf1 (Ikaros) locus
is able to rescue pro-B cell development by initiating and
maintaining the B cell gene-expression program in the absence
of E2A.758 Immunity 28, 751–762, June 2008 ª2008 Elsevier Inc.
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Previous studies demonstrated that the absence of E2A strin-
gently arrests the initiation of B cell development at the uncom-
mitted pre-pro-B cell stage (Bain et al., 1994; Zhuang et al.,
1994; Borghesi et al., 2005). We have now analyzed the function
of E2A throughout B lymphopoiesis by conditional mutagenesis,
indicating that E2A fulfills an important instructive role in the de-
velopment of bone marrow pro-B, pre-B, and immature B cells
aswell as in the formation of GCBcells in peripheral lymphoid or-
gans. E2A is, however, dispensable for immunoglobulin class-
switch recombination as well as for the generation and survival
of mature B lymphocytes (MZ B, FO B, and B1 cells), memory B
cells, andplasmacells.Molecular analyses furthermore identified
an essential function of E2A in maintaining the B cell gene-ex-
pression program and in controlling V(D)J recombination at the
IgH and Igk loci during early B cell development. The recent con-
ditional E2A analysis of Lazorchak et al. (2006b) resulted in differ-
ent conclusions, suggesting that E2A promotes the survival of
precursor andmature B lymphocytes. Because the interferon-in-
ducible Mx-cre transgene was used in this study for conditional
Tcfe2a inactivation, the interferon treatment itself providesa likely
explanation for the discrepant results in light of the fact that it
eliminates bone marrow pro-B, pre-B, and immature B cells
even in wild-type mice (Lin et al., 1998; data not shown).
In vitro culture experiments have failed to identify a critical role
for E2A in committed pro-B cells. For instance, Ab-MuLV-im-
mortalized pro-B cells are not affected by Tcfe2a inactivation be-
cause they remain viable and continue to express EBF1, Pax5,
and their target genes even after the loss of E2A (Greenbaum
et al., 2004; Lazorchak et al., 2006b). Moreover, retroviral rescue
of EBF1 expression promotes the differentiation of in vitro-cul-
tured E2A-deficient progenitors to committed pro-B cells that
show normal expression of B lymphoid genes (Seet et al.,
2004). Together, these data have led to the notion that the low
expression of the E proteins E2-2 and HEB is sufficient, in coop-
eration with EBF1 and Pax5, for maintaining the B cell gene-ex-
pression program of committed pro-B cells in the absence of
E2A (Seet et al., 2004; Greenbaum et al., 2004). Here, we have
shown that the dependency of pro-B cells on E2A is entirely dif-
ferent in vivo. First, pro-B cells are lost in vivo upon efficient de-
letion of Tcfe2a by theCd79a-cre line. Second, committed pro-B
cells, which have undergone Tcfe2a inactivation by the less effi-
cient Cd19-cre line, fail to maintain the expression of Ebf1, Pax5
and their target genes. Hence, the activity of E2A is continuously
required in vivo to maintain the B cell gene-expression program
and thus the viability of committed pro-B cells. In contrast, the
strict dependency on E2A seems to be relaxed upon long-term
in vitro culture adaptation of E2A-deficient progenitors (Seet
et al., 2004) and pro-B cells (Greenbaum et al., 2004).
Similar to pro-B cells, the generation of pre-B and immature B
cells also stringently requires the function of E2A, which cannot
be substituted by transgenic expression of the pro-survival gene
Bcl2. E2A may thus be essential for maintaining the B cell gene-
expression program also in pre-B and immature B cells, although
we could not directly test this hypothesis because of the lack of
both cell types in Cd19-cre Tcfe2afl/D mice. On the other hand,
the complete absence of Vk-Jk rearrangements in Pax5-rescued
E2A-deficient pro-B cells strongly suggests that the strict E2Adependency of Igk recombination prevents the formation of the
BCR and thus the development of immature B cells in the ab-
sence of E2A. An important role of E2A in controlling Igk recom-
bination was previously indicated by several lines of evidence.
First, E2A was identified as a DNA-binding activity interacting
with the kE2 site of the intronic iEk enhancer (Murre et al.,
1989). Second, deletion of the two E-boxes kE1 and kE2 strongly
affects Igk recombination (Inlay et al., 2004). Third, ectopic ex-
pression of E2A together with RAG1 and RAG2 induces endog-
enous Vk-Jk rearrangements in nonlymphoid cells (Romanow
et al., 2000). Fourth, no Igk rearrangement activity is detected
in Ab-MuLV-immortalized pre-B cells lacking E2A (Lazorchak
et al., 2006a). Finally, secondary Igk rearrangements and thus re-
ceptor editing are impaired in immature B cells of heterozygous
Tcfe2a+/ mice (Quong et al., 2004).
E2A has been implicated in the decision of immature splenic B
cells to differentiate into either MZ or FOB cells. MZB cells are 2-
fold increased, whereas FO B cells show a small reduction in the
spleen of heterozygous Tcfe2a+/ mice (Quong et al., 2004).
Conversely, the spleens of Id2/ or Id3/ mice contain 2-fold
lower numbers of MZ B cells with a concomitant minor increase
of FO B cells (Becker-Herman et al., 2002; Quong et al., 2004).
Lower E2A activity is therefore thought to promote MZ B cell dif-
ferentiation, whereas higher E2A activity levels may be required
for the development of FO B cell (Becker-Herman et al., 2002;
Quong et al., 2004). In the complete absence of E2A, both ma-
ture cell types are, however, still generated, although the MZ B
cells are slightly increased and the FO B cells are minimally de-
creased in the spleen of Cd23-cre Tcfe2afl/D mice. In the ab-
sence of an overt B cell phenotype, we conclude that E2A plays
no major role in the generation or maintenance of mature B cells
in peripheral lymphoid organs.
In contrast to the quiescent mature B cells, the GC B cells de-
velop at significantly reduced numbers in immunized Cd23-cre
Tcfe2afl/D or Aicda-cre Tcfe2afl/D mice. The E2A-deficient GC B
cells exhibit normal proliferation, AID (Aicda) expression, and im-
munoglobulin class-switch recombination, although they fail to
properly downregulate the expression of the cell-surface pro-
teins CD23 and CD38. The impaired formation of GC B cells is,
however, still compatible with the development of E2A-deficient
plasma cells and normal secretion of high-affinity antibodies. Al-
thoughwe have not yet identified themolecular cause underlying
theGCB cell defect, our data demonstrate that E2A is not essen-
tial for AID expression, class-switch recombination, and possibly
somatic hypermutation. The Aicda gene contains, however, two
functional E-boxes in a conserved regulatory element of its first
intron (Sayegh et al., 2003). Moreover, the endogenous Aicda
gene can be induced in splenic B cells by ectopic E2A activity
or Id2 inactivation, whereas it is repressed by retroviral expres-
sion of the HLH inhibitors Id2 or Id3 (Sayegh et al., 2003; Gonda
et al., 2003). Likewise, the class-switch recombination of acti-
vated splenic B cells is enhanced in Id2/ and Id3/ mice
(Pan et al., 1999; Sugai et al., 2003) and repressed by retroviral
Id3 expression (Quong et al., 1999). In view of our results, these
published data suggest that the three E proteins E2A, E2-2, and
HEB fulfill redundant functions in the control of Aicda transcrip-
tion and class-switch recombination because each individual
E protein appears to be nonessential for regulating these
processes.Immunity 28, 751–762, June 2008 ª2008 Elsevier Inc. 759
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E2A-Dependent Control of B LymphopoiesisThe initiation of B cell development is thought to depend on the
linear transcriptional hierarchy E2A–EBF–Pax5, because E2A
activates the Ebf1 gene and EBF1 activates the Pax5 gene
(Nutt and Kee, 2007). Upon ectopic expression in pro-T cells,
Pax5 is, however, able to activateEbf1and its target genesduring
T cell development (Fuxa et al., 2004), probably by interacting
with the proximal Ebf1 promoter (Roessler et al., 2007). Here,
we have shown that precocious Pax5 expression from the Ikzf1
locus is also sufficient to promote pro-B cell development in
E2A-deficient mice. Hence, Pax5 as the last regulator of the tran-
scriptional hierarchy is able, by feedback regulation, to initiate the
entire B cell gene-expression program; such a finding is consis-
tent with the observed strong increase of B cell development in
Ikzf1Pax5/+ mice (Souabni et al., 2002). Because no evidence ex-
ists to date for a direct regulation of Pax5 by E2A, we propose
that EBF1 and Pax5 constitute an interdependent regulatory
loop, which can be initiated andmaintained by E2A through acti-
vation of the Ebf1 gene in B cell progenitors. The conditional loss
of E2A in committed pro-B cells should, however, interrupt this
regulatory loop at the level of the Ebf1 gene, thus leading to
downregulation of the B cell gene-expression program as shown
in this study.On theother hand, theE2A-independent ectopic ex-
pression of either EBF1 or Pax5 is sufficient to initiate expression
of the B cell gene program by activating the EBF1-Pax5 regula-
tory loopeven in the absenceof E2A (Seet et al., 2004; this paper).
Our analysis of thePax5-rescuedE2A-deficient pro-B cells has
identified a nonredundant role for E2A in the control of VH-DJH re-
combination at the IgH locus. E2Awas previously shown to be re-
quired for DH-JH recombination in uncommitted lymphoid pro-
genitors probably by controlling the chromatin accessibility of
the IgH locus and the expression of the Rag1 and Rag2 genes
(Bain et al., 1994; Zhuang et al., 1994; Borghesi et al., 2005;
Hsu et al., 2003). Rag1 and Rag2 expression as well as DH-JH re-
combinationare, however, normal inPax5-rescuedE2A-deficient
pro-B cells possibly because of functional compensation of the
E2A loss by EBF1 expression. In contrast, proximal VH7183-
DJH and distal VHJ558-DJH rearrangements were strongly re-
duced in thePax5-rescuedE2A-deficient pro-Bcells.A similar re-
arrangement phenotype is observed upon deletion of the intronic
Emenhancer in the IgH locus (Perlot et al., 2005).Moreover, E2A is
known to interact in vivowith the Em enhancer possibly by binding
to the E-box mE5 (Greenbaum et al., 2004). Hence, it is conceiv-
able that E2A may mediate its effect on VH-DJH recombination
by controlling the rearrangement-inducing activity of the Em en-
hancer in analogy to its role in Igk recombination.
Our study identified an important instructive role of E2A in early
B lymphopoiesis by maintaining the B cell gene-expression pro-
gram and by controlling VH-DJH recombination at the IgH locus
in addition to its known role in regulating Igk rearrangements. Ex-
cept for GCBcell development, E2A is, however, largely dispens-
able for the formation and function of mature B lymphocytes and
plasmacells.Elucidating theE2A-dependentgene regulatorynet-
work in early B lymphocytes and identifying the redundant tran-
scription factor(s) potentially cooperating with E2A in late B lym-
phopoiesis will be interesting challenges for future investigations.
EXPERIMENTAL PROCEDURES
Detailed methods can be found in the Supplemental Data available online.760 Immunity 28, 751–762, June 2008 ª2008 Elsevier Inc.Mice
The following mice were maintained on the C57BL/6 genetic background:
Ikzf1Pax5/+ (Souabni et al., 2002), Cd19cre/+ (Rickert et al., 1997), Cd79acre/+
(Hobeika et al., 2006), CreED-30 (Schwenk et al., 1998), Vav-cre (de Boer
et al., 2003), and Vav-Bcl2 (Ogilvy et al., 1999). The heterozygous Cd19cre/+
and Cd79acre/+ genotypes are referred to as Cd19-cre and Cd79a-cre (also
known as mb1-cre), respectively. All animal experiments were carried out ac-
cording to valid project licenses, whichwere approved and regularly controlled
by the Austrian Veterinary Authorities.
Generation of a Floxed Tcfe2a Allele
The Tcfe2a targeting vector was assembled in a pSP64 plasmid with an appro-
priate polylinker for sequential insertion of DNA fragments containing the dif-
ferent gene functions shown in Figure S1A. The linearized targeting vector
was electroporated into HM-1 ES cells, and correctly targeted ES cell clones
were identified by PCR and Southern blot analyses and injected into blasto-
cysts; this was followed by the generation of Tcfe2afl/+ mice.
Generation of Cre and E47 Transgenes
TheCre genewas inserted into themouseAicda (RP24-68I7) andCd23 (RP24-
321J16) BACs by recombineering in E. coli as described (Delogu et al., 2006). A
cDNA fragment encoding the forced E47 homodimer (Sigvardsson et al., 1997)
was similarly inserted into the Ikzf1 BAC 054C2 (Research Genetics). Trans-
genic mice were generated by injection of supercoiled BACDNA into pronuclei
of C57BL/6xCBA F1 zygotes.
FACS Sorting and Analysis
FACS analyses were preformed with 4- to 6-week-old mice. The following an-
tibodies were used for flow cytometry: anti-B220 (RA3-6B2), CD4 (L3T4), CD5
(53-7.3), CD8a (53-6.7), CD19 (1D3), CD21 (7G6), CD23 (B3B4), CD25/IL-2Ra
(PC61), CD28 (37.51), CD95/Fas (Jo2), CD117/c-Kit (2B8), CD127/IL-7Ra
(A7R34), CD135/Flt3 (A2F10.1), CD138 (281-2), IgD (1.19), IgG1 (A85-1), IgM
(M41.42), Ly6C (ER-MP20), and Sca1 (D7). Unspecific antibody binding was
suppressed by preincubation with CD16/CD32 Fc-block solution (PharMin-
gen). The different hematopoietic progenitors and B cell stages were defined
by flow cytometry as described (Delogu et al., 2006; Schebesta et al., 2007).
Semiquantitative RT-PCR Analysis
cDNAwas prepared from ex vivo-sorted or in vitro-cultured hematopoietic cell
types and analyzed by semiquantitative PCR (Delogu et al., 2006) with the
primers listed in Table S1.
V(D)J Recombination Analysis
Sorted c-Kit+CD19+ pro-B cells were analyzed for IgH and Igk rearrangements
by PCR analysis as described (Fuxa et al., 2004).
Immunization and Plasma Cell Analysis
Sheep red blood cells (108 cells) or NP-KLH (100 mg in Alum) were intraperito-
neally injected into adult mice. Antibody-secreting cells (ASCs) and serum
immunoglobulin titers were determined by enzyme-linked immunospot
(ELISPOT) or immunosorbant (ELISA) assays, respectively, as described
(Delogu et al., 2006).
BrdU Labeling
Proliferating GC B cells were labeled at day 8 of immunization by intraperito-
neal injection of BrdU (1 mg) 5 hr before the mice were killed, and the incorpo-
rated BrdU was detected with an APC-anti-BrdU antibody (PharMingen).
Histological Analysis
Cryosections of the spleen from immunized mice were stained with a FITC-
anti-IgD antibody and biotinylated PNA; this was followed by detection with
an alkaline phosphatase-coupled anti-FITC antibody and horseradish peroxi-
dase-conjugated streptavidin as described (Delogu et al., 2006).
SUPPLEMENTAL DATA
Additional Experimental Procedures, thirteen figures, and two tables are avail-
able at http://www.immunity.com/cgi/content/full/28/6/751/DC1/.
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